Work

Real-world experience of belumosudil and belumosudil/ruxolitinib combination in steroid-refractory chronic graft-versus-host disease

Year: 2025

Type: article

Study design: Observational Study

Source: Bone Marrow Transplantation

DOI: 10.1038/s41409-025-02721-z

Authors: Gagan Raju, Moneeza Walji, David Nemirovsky, Sean Devlin, Ilan Goldstein, Amandeep Singh, Pamela Susman, Natasia Rodriguez, Miguel-Angel Perales, Doris M. Ponce

Institutions: Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, Cornell University

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: U.S. Department of Health and Human Services, National Heart, Lung, and Blood Institute, National Cancer Institute

Awards: G1007166040, G5317915754, G5546152554, Cancer Center Support Grant, Intestinal microbiome restoration in allogeneic stem cell transplantation

OpenAlex ID: W4414805237

FWCI:

Cites: 31

Cited by:

Related to: 10